slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 99,181-99,210
Pages 3,953
Rows per page 30
Component
99,181-99,210 of 118,578
07
Includes footnotes referencing slides 38 and 39.Deutsche Bank | Results Presentation Deck | 41 slides · Deutsche Bank
Conference presentation Investor relations Beat · Need1 hit
16
The slide provides a snapshot of credit ratings as of October 25, 2023, for a fixed income investor call.Deutsche Bank | Results Presentation Deck | 41 slides · Deutsche Bank
Conference presentation Investor relations Beat · Action1 hit
25
The slide uses a series of donut charts to illustrate portfolio composition and credit loss provisions by region and sector.Deutsche Bank | Results Presentation Deck | 41 slides · Deutsche Bank
Conference presentation Investor relations Beat · Action1 hit
29
Total outstanding is 116 billion EUR in both charts.Deutsche Bank | Results Presentation Deck | 41 slides · Deutsche Bank
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
39
Contains detailed regulatory and accounting definitions for financial metrics used throughout the deck.Deutsche Bank | Results Presentation Deck | 41 slides · Deutsche Bank
Conference presentation Investor relations Beat · Action1 hit
40
Deutsche Bank | Results Presentation Deck | 41 slidesDeutsche Bank | Results Presentation Deck | 41 slides · Deutsche Bank
Conference presentation Investor relations Beat · Action1 hit
41
Includes specific financial impact figures for the EU carve-out for Q3 2023 and 2022.Deutsche Bank | Results Presentation Deck | 41 slides · Deutsche Bank
Conference presentation Investor relations Beat · Action1 hit
03
Includes logo, page number, and footer details.Deutsche Bank | Results Presentation Deck | 47 slides · Deutsche Bank
Conference presentation Investor relations Beat · Attention1 hit
06
The slide uses a process flow diagram to connect capital optimization to strategic growth pillars and the bank's business model.Deutsche Bank | Results Presentation Deck | 47 slides · Deutsche Bank
Conference presentation Investor relations Beat · NeedLoop · Golden Circle1 hit
07
Deutsche Bank | Results Presentation Deck | 47 slidesDeutsche Bank | Results Presentation Deck | 47 slides · Deutsche Bank
Conference presentation Investor relations Beat · NeedLoop · Golden Circle1 hit
40
Figures reflect current status of individual matters and provisions; litigation provisions and contingent liabilities are subject to potential further developments; litigation provisions and contingent liabilities include civil litigation and regulatory enforcement matters.Deutsche Bank | Results Presentation Deck | 47 slides · Deutsche Bank
Conference presentation Investor relations Beat · Visualization1 hit
41
ME = month-end; MTD = month-to-dateDeutsche Bank | Results Presentation Deck | 47 slides · Deutsche Bank
Conference presentation Investor relations Beat · Visualization1 hit
45
This is a standard appendix slide for financial reporting disclosures.Deutsche Bank | Results Presentation Deck | 47 slides · Deutsche Bank
Conference presentation Investor relations Beat · Visualization1 hit
46
Deutsche Bank | Results Presentation Deck | 47 slidesDeutsche Bank | Results Presentation Deck | 47 slides · Deutsche Bank
Conference presentation Investor relations Beat · Visualization1 hit
03
The slide uses a large group photo to emphasize inclusivity and brand mission.Essity | Results Presentation Deck | 25 slides · Essity
Conference presentation Investor relations Beat · Setup1 hit
06
Includes brand marketing imagery for Libresse on the right side.Essity | Results Presentation Deck | 25 slides · Essity
Conference presentation Investor relations Beat · Evidence1 hit
07
The chart uses a standard waterfall bridge to explain the 8.5% reported growth.Essity | Results Presentation Deck | 25 slides · Essity
Conference presentation Investor relations Beat · Evidence1 hit
08
The chart uses a waterfall-bridge structure to explain margin variance.Essity | Results Presentation Deck | 25 slides · Essity
Conference presentation Investor relations Beat · Evidence1 hit
18
The slide uses a background photo of a facility with solar panels to visually reinforce the sustainability message.Essity | Results Presentation Deck | 25 slides · Essity
Conference presentation Investor relations 1 hit
23
Includes company logo and a brand portfolio logo bar at the bottom.Essity | Results Presentation Deck | 25 slides · Essity
Conference presentation Investor relations 1 hit
01
Eutelsat | Results Presentation Deck | 18 slidesEutelsat | Results Presentation Deck | 18 slides · Eutelsat Group
Conference presentation Investor relations Beat · Attention1 hit
04
Eutelsat | Results Presentation Deck | 18 slidesEutelsat | Results Presentation Deck | 18 slides · Eutelsat Group
Conference presentation Investor relations Beat · NeedLoop · Golden Circle1 hit
10
The chart uses a horizontal bar format to indicate development stage (all currently in Phase 1/2).Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
18
The slide uses Kaplan-Meier curves to demonstrate clinical efficacy of the platform's drug prioritization.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
25
The slide features a 3D molecular visualization and a UI overlay representing various drug discovery parameters (Potency, Selectivity, etc.).Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
31
The slide outlines a standard clinical trial progression from dose escalation to expansion, with a focus on establishing RP2D and evaluating ORR.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
36
The slide presents preclinical efficacy data for a CDK7 inhibitor ('617) in ovarian (OVCAR3) and triple-negative breast cancer (HCC70) models.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
38
The slide uses a heatmap to visualize synergy (green) vs no synergy (light green) across different drug combinations and patient samples.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
39
Uses a Venn diagram to illustrate overlap between peripheral blood and tumour gene expression data.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
47
Includes two scientific citations for the mechanism and brain penetration.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit